Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-06

Clinical Trial Update: Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis [NA]

View source ↗

Summary

A clinical trial comparing ixekizumab to secukizumab in patients over 70 with psoriasis is not yet recruiting. Sponsor: Second Affiliated Hospital, School of Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosentyx (secukinumab)
  • TALTZ (IXEKIZUMAB)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Over 70-year-old Patients with Psoriasis | NA | Status: NOT_YET_RECRUITING